Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 17 active records with this name as holder; 4 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
26 acceptance records as first applicant, grouped into 15 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Latamoxef Sodium for Injection 3 records · Latest accepted 2026/10/22
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601940 | Supplement | 2026/10/22 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.; Zhejiang Hui Di Sen Pharma Co., Ltd. romanized | CDE ↗ |
| CYHB2601939 | Supplement | 2026/10/22 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.; Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2601938 | Supplement | 2026/10/22 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd.; Haerbin Yu Heng Pharmaceutical Co., Ltd. romanized | CDE ↗ |
磷苯妥英钠注射用浓溶液 · No verified English name 2 records · Latest accepted 2026/03/07
Generic · 2
Thioctic Acid Injection 2 records · Latest accepted 2025/06/28
Supplement · 1Generic · 1
Polymyxin B sulfate for Injection 1 records · Latest accepted 2025/04/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2501237 | Generic | 2025/04/01 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Clindamycin Injection 6 records · Latest accepted 2024/11/07
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401836 | Supplement | 2024/11/07 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401835 | Supplement | 2024/11/07 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401046 | Supplement | 2024/07/16 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401044 | Supplement | 2024/07/16 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2302641 | Supplement | 2023/12/01 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2302640 | Supplement | 2023/12/01 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Ademetionine 1,4 - Butanedisulfonate For Injection 1 records · Latest accepted 2024/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400108 | Generic | 2024/01/09 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Teicoplanin for Injection 1 records · Latest accepted 2023/12/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303391 | Generic | 2023/12/08 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Thioctic Acid Tablets 2 records · Latest accepted 2023/11/30
Generic · 2
Famotidine Injection 1 records · Latest accepted 2023/03/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300718 | Generic | 2023/03/07 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Pentoxifylline Injection 1 records · Latest accepted 2022/11/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201865 | Generic | 2022/11/01 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Peramivir Injection 1 records · Latest accepted 2022/10/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201738 | Generic | 2022/10/14 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Voriconazole for Injection 1 records · Latest accepted 2022/08/15
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201297 | Generic | 2022/08/15 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Ornidazole Tablets 1 records · Latest accepted 2022/07/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201100 | Generic | 2022/07/19 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Piracetam Tablets 1 records · Latest accepted 2022/06/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250347 | Supplement | 2022/06/14 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Febuxostat Tablets 2 records · Latest accepted 2021/07/05
Generic · 2
Changes in the last 90 days
10 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Accepted: 3 applicationsNo longer listed under review: 4 applicationsSupplement delivery: 3 applications
- 2026/11/10No longer listed under review
Polymyxin B sulfate for Injection
CYHS2501237
Fact date: 2026/11/10 · Date added to this site: 2026/11/10
Accepted: 2025/04/01
no longer on the CDE under-review list as of the data cut-off; the review / approval outcome is to be checked
View source ↗ - 2026/11/07No longer listed under review
Latamoxef Sodium for Injection
CYHB2601940
Fact date: 2026/11/07 · Date added to this site: 2026/11/07
Accepted: 2026/10/22
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 47
NMPA · Table row 47 ↗ View source ↗ - 2026/11/07No longer listed under review
Latamoxef Sodium for Injection
CYHB2601939
Fact date: 2026/11/07 · Date added to this site: 2026/11/07
Accepted: 2026/10/22
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 46
NMPA · Table row 46 ↗ View source ↗ - 2026/11/07No longer listed under review
Latamoxef Sodium for Injection
CYHB2601938
Fact date: 2026/11/07 · Date added to this site: 2026/11/07
Accepted: 2026/10/22
no longer on the CDE under-review list as of the data cut-off; NMPA published approval-document delivery for this acceptance number on 2026/11/06 (approval no.: —; approval date: 2026/11/05); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 45
NMPA · Table row 45 ↗ View source ↗ - 2026/11/05Supplement delivery
Latamoxef Sodium for Injection
CYHB2601940
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 47 ↗ - 2026/11/05Supplement delivery
Latamoxef Sodium for Injection
CYHB2601939
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 46 ↗ - 2026/11/05Supplement delivery
Latamoxef Sodium for Injection
CYHB2601938
Fact date: 2026/11/05 · Publication date: 2026/11/06 · Date added to this site: 2026/11/06
Supplemental application; excluded from new marketing approvals.
View source · Table row 45 ↗ - 2026/10/22Accepted
Latamoxef Sodium for Injection
CYHB2601940
Fact date: 2026/10/22 · Date added to this site: 2026/10/23
View source ↗ - 2026/10/22Accepted
Latamoxef Sodium for Injection
CYHB2601939
Fact date: 2026/10/22 · Date added to this site: 2026/10/23
View source ↗ - 2026/10/22Accepted
Latamoxef Sodium for Injection
CYHB2601938
Fact date: 2026/10/22 · Date added to this site: 2026/10/23
View source ↗
Under review
2 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| 磷苯妥英钠注射用浓溶液 · No verified English name | CYHS2600629 | Generic | 2026/03/07 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| 磷苯妥英钠注射用浓溶液 · No verified English name | CYHS2600628 | Generic | 2026/03/07 | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
17 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Ademetionine 1,4 - Butanedisulfonate For Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20254936 | 2025/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thioctic Acid Tablets | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20254844 | 2025/07/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Thioctic Acid Tablets | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20254843 | 2025/07/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Teicoplanin for Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20253762 | 2025/04/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Famotidine Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20244786 | 2024/09/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Voriconazole for Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20244469 | 2024/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pentoxifylline Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20244060 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Peramivir Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20243908 | 2024/06/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Tablets | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20243800 | 2024/05/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piracetam Tablets | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20247002 | 2024/01/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Febuxostat Tablets | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20233188 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Febuxostat Tablets | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20233189 | 2023/02/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20223404 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ornidazole Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20223403 | 2022/06/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofloxacin Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20223246 | 2022/04/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Doxofylline Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20213990 | 2021/12/31 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | 国药准字H20213708 | 2021/09/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
4 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 卡巴匹林钙 · No verified English name | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Y20190006940 | A | — | CDE ↗ |
| 洛伐他汀 · No verified English name | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Y20190005846 | A | 2025/11/13 | CDE ↗ |
| 硫酸庆大霉素 · No verified English name | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Y20190002059 | A | 2025/05/29 | CDE ↗ |
| 硫辛酸 · No verified English name | Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | Y20190001222 | A | — | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
4 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Clindamycin Injection | CYHB2101956 | Supplement | 2021/10/11 | Guang'an Kingday Pharma & Chem Co., Ltd; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| Clindamycin Injection | CYHS2101129 | Generic | 2021/05/14 | Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| Clindamycin Injection | CYHS2101128 | Generic | 2021/05/14 | Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
| Clindamycin Injection | CYHS2101127 | Generic | 2021/05/14 | Guangdong Jin Cheng Jin Su Pharmaceutical Co., Ltd. romanized; Fuan Pharmaceutical Group Yantai Justaware Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.